As a complementary approach, bombesin-based tracers have shown promising results in lower-grade, well-differentiated tumours [10] but also in advanced and aggressive PCa [10, 11], which no longer show sufficient PSMA expression [22]. Here, FOLH1 is linked to neoplasm.